<strong>From emergency to security: Healthcare collaboration in the post-Covid world</strong>

From emergency to security: Healthcare collaboration in the post-Covid world

New research reveals that the urgency of combating Covid-19 drove closer collaboration between biopharma and government.
<strong>Better rules make better relationships</strong>

Better rules make better relationships

Covid-19 forced governments and biopharma companies to work together more than ever before, and at unprecedented speed, to approve products for the public good.
<strong>Growth beyond crisis: How can governments help their biopharma sectors to thrive?</strong>

Growth beyond crisis: How can governments help their biopharma sectors to thrive?

From rapidly accelerated development and manufacturing to improved public-private sector collaboration, the impact of the pandemic on the biopharma sector has been nothing short of phenomenal.

Insights from the 2021 Global Biopharma Resilience Index



Biopharma Resilience Testimonial: Lakes Bioscience and NHC

Learn more about Lakes Bioscience and NHC are harnessing virtual reality to upskill talent in biomanufacturing, and get medicine to patients faster. More on www.cytiva.com/resilience

Thursday, June 2, 2022 | 4:12

Biopharma Resilience Testimonial: Lakes Bioscience and NHC 4:12
Biopharma Resilience Testimonial: Bionova Scientific 4:12
Biopharma Resilience Testimonial: Arranta Bio 4:10
Biopharma Resilience: CDMOs secure supply chain management
Biopharma resilience: Saudi Arabia government leaders discuss agile manufacturing beyond borders 3:39